The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

With enough supplies, Israel looks to re-route AstraZeneca vaccine delivery

Wed, 21st Apr 2021 10:45

* Israel bought enough vaccine from others, official says

* Seeks to divert AstraZeneca shipment to other countries

* Israel's vaccine rollout one of the fastest in the world

JERUSALEM, April 21 (Reuters) - Israel no longer wants
AstraZeneca's COVID-19 vaccine and is exploring with the
company whether a big shipment in the pipeline could be sent
elsewhere, Israel's pandemic coordinator said on Wednesday.

"We are trying to find the best solution. After all, we
don't want (the vaccines) to get here and have to throw them
into the trash," the official, Nachman Ash, told Army Radio,
saying Israel's needs were being met by other suppliers.

In his remarks, Ash made no reference to AstraZeneca’s
vaccine having been associated with very rare blood clots in
Europe. Many countries there resumed administering it after the
European Union's drug watchdog said benefits outweighed risks.

Israel cast a wide net last year when trying to secure
vaccine doses at the height of the pandemic and pre-ordered from
a number of companies.

It largely settled on the Pfizer/BioNTech
vaccine, launching one of the world's swiftest rollouts.
COVID-19 infections in Israel have dropped dramatically and the
economy has reopened.

Israel is also buying the COVID-19 vaccines from Moderna
, which uses a similar messenger RNA (mRNA) technology.

Ash said that with supplies secure through 2022, Israel no
longer required the 10 million doses it agreed to purchase from
AstraZeneca.

"They can certainly be used in other places in the world. At
the moment, we are trying to find, along with the company, the
best way to do this," he said.

"We believe it would be best if they (the vaccines) did not
come to Israel and we agree with the company on some sort of way
to divert them elsewhere."

Officials at AstraZeneca had no immediate comment.

Around 81% of Israeli citizens or residents over 16 - the
age group eligible for the Pfizer/BioNTech vaccine in Israel -
have received both doses.

Some 167,000 of the 5.2 million Palestinians in the occupied
West Bank and Islamist Hamas-run Gaza have had at least one dose
of vaccine, with supplies coming in from Israel, Russia, the
United Arab Emirates, the global COVAX vaccine-sharing programme
and China.
(Reporting by Jeffrey Heller and Ari Rabinovitch. Editing by
Mark Potter)

More News
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more
27 Dec 2023 17:04

Rate-cut optimism, autos push UK stocks higher

FTSE 100 up 0.4%, FTSE 250 adds 0.5%

*

Read more
27 Dec 2023 17:02

LONDON MARKET CLOSE: Stocks start week higher as 2024 draws to close

(Alliance News) - Equities in London kicked off an abbreviated trading week with gains on Wednesday, on continued US interest rate optimism at the end of 2024.

Read more
27 Dec 2023 14:25

London close: Stocks maintain gains amid post-Christmas rally

(Sharecast News) - London's stock markets closed in positive territory on Wednesday, buoyed by a global surge in stock prices as the S&P 500 neared an all-time high on Wall Street.

Read more
27 Dec 2023 12:06

LONDON MARKET MIDDAY: Stocks hold onto gains amid US rate cut hopes

(Alliance News) - London's FTSE 100 index was outperforming other European stock-price measures at midday on Wednesday, boosted by gains for miners and industrials.

Read more
27 Dec 2023 11:20

London midday: Stocks ride global wave of post-Christmas optimism

(Sharecast News) - London's equity markets were still above the waterline at lunchtime on Wednesday, following a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:48

LONDON MARKET OPEN: FTSE 100 gains led by miners and industrials

(Alliance News) - Stock prices in London opened in the green on Wednesday, as hopes for US interest rate cuts in the new year continued to propel global equities higher.

Read more
27 Dec 2023 08:26

London open: FTSE takes cues from Wall Street 'Santa rally'

(Sharecast News) - London's stocks returned from the Christmas break in the green on Wednesday, boosted by a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:24

TOP NEWS: AstraZeneca buys Gracell to "enrich" cell therapy pipeline

(Alliance News) - AstraZeneca PLC on Tuesday said it has agreed to acquire Gracell Biotechnologies Inc, paying about USD1.2 billion for the clinical-stage company.

Read more
27 Dec 2023 07:52

LONDON BRIEFING: AstraZeneca buys Gracell Biotech; COPL CEO resigns

(Alliance News) - Stocks in London were expected to make gains at Wednesday's market open, as investors continued to pin their hopes on US interest rate cuts.

Read more
27 Dec 2023 07:02

AstraZeneca to buy Gracell Technologies for $1.2bn

(Sharecast News) - AstraZeneca on Wednesday said it was buying Gracell Biotechnologies, a global clinical-stage biopharmaceutical company developing cell therapies for the treatment of cancer and autoimmune diseases, for $1.2bn.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.